Controlled Substances - As enacted, authorizes additional healthcare providers to directly administer buprenorphine mono or buprenorphine without the use of naloxone; adds that prescribing a buprenorphine product to nursing mother or prescribing an injectable mono product does not restrict certain healthcare providers from prescribing a buprenorphine product for the treatment of opioid use disorder without naloxone. - Amends TCA Title 53, Chapter 11.

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 31 Sponsors

No summary has been published for this bill. The full text is on the Bill text tab.